NCT05576727

Brief Summary

In recent years, researches on the natural history and risk factors of intracranial unruptured aneurysms have become a hot topic at home and abroad. However, risk factors for aneurysm rupture is still unclear yet. The investigators' preliminary study focused on constructing a rupture risk prediction system for intracranial unruptured aneurysm in the investigators' single center. The investigators' result showed that three significant factors (sex, abnormal serum tumor necrosis factor (TNF)-α and coincidence of thin-walled regions (TWR) and normalized wall shear stress (NWSS)) stood out by using logistic regression to explore the rupture risk factors of intracranial unruptured aneurysms, which could help guide the clinical treatment of intracranial unruptured aneurysms. This study is to evaluate and improve the rupture predict model of intracranial unruptured aneurysm in multi-neurosurgical centers.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
19mo left

Started Jan 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress69%
Jan 2023Dec 2027

First Submitted

Initial submission to the registry

October 10, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 12, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

January 1, 2023

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

October 13, 2022

Status Verified

October 1, 2022

Enrollment Period

5 years

First QC Date

October 10, 2022

Last Update Submit

October 11, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Predictive value of coincidence of TWR and NWSS for unruptured aneurysm rupture

    at 5 years, the value of the factor (coincidence of TWR and NWSS) to predict aneurysm rupture risk will be analyzed

    at 5 year

  • Predictive value of serum TNF-α for unruptured aneurysm rupture

    at 5 years, the value of the factor (serum TNF-α) to predict aneurysm rupture risk will be analyzed

    at 5 year

  • Predictive value of sex for unruptured aneurysm rupture

    at 5 years, the value of the factor (sex) to predict aneurysm rupture risk will be analyzed

    at 5 year

Secondary Outcomes (3)

  • Predictive value of coincidence of TWR and NWSS for unruptured aneurysm growth

    at 5 year

  • Predictive value of serum TNF-α for unruptured aneurysm growth

    at 5 year

  • Predictive value of sex for unruptured aneurysm growth

    at 5 year

Study Arms (1)

Unruptured Intracranial Aneurysm

Other: Unruptured intracranial aneurysms

Interventions

Extensive clinical, biological and imaging data of unruptured intracranial aneurysm patients will be recorded during a 5 years follow-up.

Unruptured Intracranial Aneurysm

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The enrolled patients are who have unruptured asymptomatic aneurysm with a clinical, a biological and an imaging follow-up, without any relative treatment.

You may qualify if:

  • Diagnosis of aneurysm by digital subtraction angiography (DSA);
  • Age between 18-70 years old;
  • Informed consent form for this study was signed

You may not qualify if:

  • Dissecting aneurysms and saccular aneurysms with other vascular diseases such as arteriovenous malformations, moyamoya disease, and arteriovenous fistulas were excluded;
  • Combined with serious systemic diseases;
  • Patients who cannot receive MRI/magnetic resonance angiography (MRA) examinations due to severely impaired renal function, allergy, space claustrophobia or internal implants in the body.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Second Affiliated Hospital, School of Medicine, Zhejiang University

Hangzhou, Zhejiang, 310029, China

Location

MeSH Terms

Conditions

Intracranial Aneurysm

Condition Hierarchy (Ancestors)

Intracranial Arterial DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesAneurysmVascular DiseasesCardiovascular Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 10, 2022

First Posted

October 12, 2022

Study Start

January 1, 2023

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

October 13, 2022

Record last verified: 2022-10

Locations